Public health
Self-reported effects of attending the Health Foundation’s Co-Creating Health self-management programme for patients with type 2 diabetes mellitus in London, England
 
More details
Hide details
 
Submission date: 2013-10-08
 
 
Final revision date: 2013-11-22
 
 
Acceptance date: 2013-11-24
 
 
Online publication date: 2014-08-29
 
 
Publication date: 2014-08-31
 
 
Arch Med Sci 2014;10(4):773-781
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: The purpose of this study was to determine the impact of the Health Foundation’s Co-Creating Health (CCH) group self-management programme (SMP) for adult patients with type 2 diabetes on patient activation and quality of life.
Material and methods: We conducted a multisite longitudinal study of 283 pa­tients (mean age 62.3 years, SD 11.1; 43% ethnic minority; 51% female). Primary outcomes were patient activation, and diabetes and health related quality of life. Secondary outcomes included health status, psychological distress, and self-management ability. Data were collected immediately before the first SMP session (baseline) and 6 months after completing the programme. Quantitative analyses were based on mixed models using intent-to-treat and per-protocol procedures.
Results: Sixty percent of patients who signed up for SMP completed the programme. Patient activation significantly improved 6 months after the SMP (p < 0.0001), and 60.2% of course completers showed meaningful improvement. Diabetes-related quality of life also improved significantly 6 months post course (p < 0.0001). About a quarter of SMP completers showed substantial improvement in self-management skills.
Conclusions: Attending the UK SMP for adults with type 2 diabetes leads to improvements in patient activation, diabetes-related quality of life, and improved confidence and ability to self-manage their condition. Improvement in patient activation is an important finding because activated patients participate in collaborative decision-making with their clinicians, report improved health-related behaviours and clinical outcomes, and better adhere to treatment.
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top